New York A03283 mandates gene synthesis providers and equipment manufacturers to comply with health department regulations, including identifying.

New York A03283, known as the "bioterrorism prevention act," amends the public health law by adding a new article on gene synthesis labs. It requires gene synthesis providers and manufacturers of gene synthesis equipment to follow rules and regulations issued by the department of health. These regulations include identifying potentially dangerous genetic sequences, screening potential customers, and retaining records of genes synthesized and delivered. The department is directed to use generally accepted industry standards and consider recommendations from relevant organizations.

New York A03283 mandates gene synthesis providers and equipment manufacturers to comply with health department regulations, including identifying.

New York A03283, known as the "bioterrorism prevention act," amends the public health law by adding a new article on gene synthesis labs. It requires gene synthesis providers and manufacturers of gene synthesis equipment to follow rules and regulations issued by the department of health. These regulations include identifying potentially dangerous genetic sequences, screening potential customers, and retaining records of genes synthesized and delivered. The department is directed to use generally accepted industry standards and consider recommendations from relevant organizations.